Lumos Pharma, Inc. (LUMO) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 4 Buy, 3 Hold.
The consensus price target is $16.50 (low: $7.00, high: $26.00), representing an upside of 280.2% from the current price $4.34.
LUMO Stock — 12-Month Price Forecast
$16.50
▲ +280.18% Upside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Lumos Pharma, Inc., the average price target is $16.50, with a high forecast of $26.00, and a low forecast of $7.00.
The average price target represents a +280.18% change from the last price of $4.34.
Highest Price Target
$26.00
Average Price Target
$16.50
Lowest Price Target
$7.00
LUMO Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Lumos Pharma, Inc. in the past 3 months
